Table 2.
Joinpoint analysis of trend for pancreatic cancer survival rate, 2010–2016
| Survival rate | Trend 1 | Trend 2 | Trend 3 | |||
|---|---|---|---|---|---|---|
|
| ||||||
| Years | Adjusted AAPCa (95% CI) | Years | Adjusted AAPCa (95% CI) | Years | Adjusted AAPCa (95% CI) | |
|
| ||||||
| 6 months | 2010–2016 | 5.5% (1.2–9.9)* | 2010–2013 | 2.6% (−11.9–19.5) | 2013–2016 | 4.8% (−12.2–25.1) |
| 12 months | 2010–2016 | 13.6% (0.3–28.7)* | 2010–2013 | 7.0% (−46.6–114.2) | 2013–2016 | 27.6% (−12.8–86.9) |
| 24 months | 2010–2015 | 25.1% (6.1–42.3)* | 2010–2013 | 12.5% (−44.4–127.8) | 2013–2015 | 5.5% (−2.6–24.6) |
Notes:
a
Adjusted for sex, age, Charlson comorbidity, ECOG PS, site of metastatic organ, smoking history, and institute of treatment.
*
P<0.05.
Abbreviations: AAPC, average annual percent change; ECOG PS, European Cooperative Oncology Group Performance Status.